original ) (raw )Serum Neopterin, an Immune Activation Marker, Independently Predicts Disease Progression in Advanced HIV-1 Infection
John Spritzler
Clinical Infectious Diseases, 2005
View PDFchevron_right
Utility of Serum Neopterin and Serum IL-2 Receptor Levels to Predict Absolute CD4 T Lymphocyte Count in HIV Infected Cases
Richa Dewan
Interdisciplinary perspectives on infectious diseases, 2013
View PDFchevron_right
Association Between Neopterin Levels and Outcome in 30 Day HIV/AIDS Naive Patients
Usman Hadi
Biomolecular and Health Science Journal
View PDFchevron_right
Increased serum neopterin in patients with HIV-1 infection is correlated with reduced in vitro interleukin-2 production
Mario Clerici
Clinical & Experimental Immunology, 2008
View PDFchevron_right
Urinary neopterin concentrations and T-cell subset data in HIV-1 infection
gilbert reibnegger
Klinische Wochenschrift, 1990
View PDFchevron_right
Serum neopterin, an immune activation marker, independently predicts disease progression in advanced HN-1 infection
John Spritzler
Clinical Infectious Diseases, 2005
View PDFchevron_right
Neopterin and soluble CD14 levels as indicators of immune activation in cases with low anti-HCV reactivity and true HCV infection
Zafer Habip
Acta Virologica, 2017
View PDFchevron_right
NEOPTERIN AND CD4+ T-LYMPHOCYTES IN STAGE I HIV INFECTION (Neopterin dan Limfosit T-CD4+ di Infeksi HIV Stadium I)
ERWIN ASTHA TRIYONO
Indonesian Journal of Clinical Pathology and Medical Laboratory, 2018
View PDFchevron_right
Neopterin and beta 2-microglobulin as prognostic indices in human immunodeficiency virus type 1 infection
gilbert reibnegger
Infection, 1991
View PDFchevron_right
Are Plasma Biomarkers of Immune Activation Predictive of HIV Progression: A Longitudinal Comparison and Analyses in HIV-1 and HIV-2 Infections?
Katie Flanagan
PLoS ONE, 2012
View PDFchevron_right
Neopterin and beta 2-microglobulin as serum markers in a placebo-controlled anti-HIV therapy trial
Lars Teglbjærg , Finn Black
European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies, 1995
View PDFchevron_right
Neopterin and Biochemical Parameters as Indicators of Predicting HIV Disease Progression and Treatment Response: A Cross-sectional Study in Ghana
Louis Kwantwi
Journal of Advances in Medicine and Medical Research, 2019
View PDFchevron_right
Highly Active Antiretroviral Therapy (HAART) and Circulating Markers of Immune Activation: Specific Effect of HAART on Neopterin
Huiping Zhou
Clinical and Vaccine Immunology, 2000
View PDFchevron_right
Immunological and virological markers of HIV-disease progression
Nancy McCain
Journal of the Association of Nurses in AIDS Care, 1996
View PDFchevron_right
Immune changes in HIV-1 infection: significant correlations and differences in serum markers and lymphoid phenotypic antigens
William Cumberland
Clinical immunology and immunopathology, 1992
View PDFchevron_right
Neopterin and soluble CD14 (sCD14) levels as immunoactivation markers in aHBc-only cases
Zafer Habip
Future Virology, 2017
View PDFchevron_right
Association of Soluble CD14 and Inflammatory Biomarkers With HIV-2 Disease Progression
Sophie Matheron
Clinical Infectious Diseases, 2012
View PDFchevron_right
Neopterin: An early marker of development of pre-AIDS conditions in HIV-seropositive individuals
John Fitzharris
Clinical Immunology Newsletter, 1988
View PDFchevron_right
Cerebrospinal fluid neopterin: an informative biomarker of central nervous system immune activation in HIV-1 infection
Dietmar Fuchs
AIDS Research and Therapy, 2010
View PDFchevron_right
Specific Immune Response to Human Immunodeficiency Virus (HIV)-1 in Patients Assessed Through the Production of Interferon-gamma and Interleukin-4 in HIV-1 p24-Activated Whole Blood Cultures: Relationship with the Viral Load in Plasma
Georges Lion , Yves Mouton
Scandinavian Journal of Immunology, 1999
View PDFchevron_right
Cerebrospinal Fluid Neopterin Levels in 159 Neurologically Asymptomatic Persons Infected with the Human Immunodeficiency Virus (HIV-1): Relationship to Immune Status
Daniel Lucey
Viral Immunology, 1993
View PDFchevron_right
Residual Viraemia in HIV-1-Infected Patients with Plasma Viral Load ≤20 copies/ml is Associated with Increased Blood Levels of Soluble Immune Activation Markers
Jan Gerstoft
Scandinavian Journal of Immunology, 2008
View PDFchevron_right
2-Microglobulin and Immunoglobulins are More Useful Markers of Disease Progression in HIV than Neopterin and Adenosine Deaminase
Pere Domingo
Annals of Clinical Biochemistry: An international journal of biochemistry and laboratory medicine, 1999
View PDFchevron_right
Impact of Select Immunologic and Virologic Biomarkers on CD4 Cell Count Decrease in Patients with Chronic HIV‐1 Subtype C Infection: Results from Sinikithemba Cohort, Durban, South Africa
Elena Losina
Clinical Infectious Diseases, 2009
View PDFchevron_right
Evaluation of HIV-DNA, soluble CD14 and inflammatory markers in HIV-1 positive patients receiving antiretroviral therapy
Isabella Bon
Journal of Clinical Virology, 2016
View PDFchevron_right
Urinary neopterin concentrations vs total neopterins for clinical utility
gilbert reibnegger
Clinical chemistry, 1989
View PDFchevron_right
Immunological Markers of Disease Progression in Patients Infected with the Human Immunodeficiency Virus
Pedro Contreras
1997
View PDFchevron_right